VERMILION ENERGY INC (VET) Stock Fundamental Analysis

NYSE:VET • CA9237251058

10.03 USD
+0.04 (+0.4%)
At close: Feb 13, 2026
10.03 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, VET scores 2 out of 10 in our fundamental rating. VET was compared to 206 industry peers in the Oil, Gas & Consumable Fuels industry. VET has a bad profitability rating. Also its financial health evaluation is rather negative. VET is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year VET has reported negative net income.
  • In the past year VET had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: VET reported negative net income in multiple years.
  • In the past 5 years VET always reported a positive cash flow from operatings.
VET Yearly Net Income VS EBIT VS OCF VS FCFVET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -3.93%, VET is doing worse than 74.76% of the companies in the same industry.
  • VET has a Return On Equity of -8.65%. This is in the lower half of the industry: VET underperforms 72.33% of its industry peers.
  • The Return On Invested Capital of VET (3.51%) is worse than 66.02% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for VET is significantly below the industry average of 21.98%.
  • The 3 year average ROIC (10.72%) for VET is well above the current ROIC(3.51%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -3.93%
ROE -8.65%
ROIC 3.51%
ROA(3y)4.74%
ROA(5y)-0.65%
ROE(3y)9.7%
ROE(5y)-15.85%
ROIC(3y)10.72%
ROIC(5y)N/A
VET Yearly ROA, ROE, ROICVET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

  • VET has a Operating Margin (12.83%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of VET has grown nicely.
  • Looking at the Gross Margin, with a value of 67.54%, VET is in the better half of the industry, outperforming 74.76% of the companies in the same industry.
  • In the last couple of years the Gross Margin of VET has remained more or less at the same level.
Industry RankSector Rank
OM 12.83%
PM (TTM) N/A
GM 67.54%
OM growth 3Y-29.16%
OM growth 5Y2.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.52%
GM growth 5Y0.95%
VET Yearly Profit, Operating, Gross MarginsVET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • VET has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for VET has been reduced compared to 1 year ago.
  • VET has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for VET is higher compared to a year ago.
VET Yearly Shares OutstandingVET Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VET Yearly Total Debt VS Total AssetsVET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.46, we must say that VET is in the distress zone and has some risk of bankruptcy.
  • VET has a worse Altman-Z score (0.46) than 63.11% of its industry peers.
  • A Debt/Equity ratio of 0.49 indicates that VET is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.49, VET is in line with its industry, outperforming 47.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 0.46
ROIC/WACC0.47
WACC7.53%
VET Yearly LT Debt VS Equity VS FCFVET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.81 indicates that VET may have some problems paying its short term obligations.
  • VET has a Current ratio of 0.81. This is in the lower half of the industry: VET underperforms 67.96% of its industry peers.
  • VET has a Quick Ratio of 0.81. This is a bad value and indicates that VET is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.71, VET is doing worse than 65.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.71
VET Yearly Current Assets VS Current LiabilitesVET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 70.33% over the past year.
  • The Revenue has decreased by -2.34% in the past year.
  • Measured over the past years, VET shows a small growth in Revenue. The Revenue has been growing by 1.65% on average per year.
EPS 1Y (TTM)70.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.94%
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-2.42%
Revenue growth 5Y1.65%
Sales Q2Q%-5.34%

3.2 Future

  • VET is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 70.83% yearly.
  • VET is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.29% yearly.
EPS Next Y-275.38%
EPS Next 2Y100.78%
EPS Next 3Y70.83%
EPS Next 5YN/A
Revenue Next Year-3.04%
Revenue Next 2Y-2.44%
Revenue Next 3Y-1.84%
Revenue Next 5Y-0.29%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VET Yearly Revenue VS EstimatesVET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
VET Yearly EPS VS EstimatesVET Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • VET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 22.36, VET is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of VET is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, VET is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 22.36
VET Price Earnings VS Forward Price EarningsVET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VET indicates a rather cheap valuation: VET is cheaper than 88.83% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.57
VET Per share dataVET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • VET's earnings are expected to grow with 70.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y100.78%
EPS Next 3Y70.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • VET has a Yearly Dividend Yield of 3.69%.
  • VET's Dividend Yield is a higher than the industry average which is at 3.63.
  • Compared to an average S&P500 Dividend Yield of 1.79, VET pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.69%

5.2 History

  • The dividend of VET decreases each year by -28.87%.
  • VET has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of VET decreased in the last 3 years.
Dividend Growth(5Y)-28.87%
Div Incr Years2
Div Non Decr Years2
VET Yearly Dividends per shareVET Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of VET are negative and hence is the payout ratio. VET will probably not be able to sustain this dividend level.
DP-32.97%
EPS Next 2Y100.78%
EPS Next 3Y70.83%
VET Yearly Income VS Free CF VS DividendVET Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

More info and screens

Find the best dividend stocksShow peers with best dividend

VERMILION ENERGY INC

NYSE:VET (2/13/2026, 8:04:00 PM)

After market: 10.03 0 (0%)

10.03

+0.04 (+0.4%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-05
Earnings (Next)N/A
Inst Owners45.98%
Inst Owner Change5.01%
Ins Owners0.49%
Ins Owner ChangeN/A
Market Cap1.80B
Revenue(TTM)1.89B
Net Income(TTM)-234.26M
Analysts70.67
Price Target10.6 (5.68%)
Short Float %10.07%
Short Ratio9.87
Dividend
Industry RankSector Rank
Dividend Yield 3.69%
Yearly Dividend0.34
Dividend Growth(5Y)-28.87%
DP-32.97%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-914.6%
Min EPS beat(2)-1768.81%
Max EPS beat(2)-60.4%
EPS beat(4)0
Avg EPS beat(4)-502.97%
Min EPS beat(4)-1768.81%
Max EPS beat(4)-58.17%
EPS beat(8)0
Avg EPS beat(8)-396.27%
EPS beat(12)3
Avg EPS beat(12)1290.22%
EPS beat(16)5
Avg EPS beat(16)978.47%
Revenue beat(2)0
Avg Revenue beat(2)-22.1%
Min Revenue beat(2)-26.83%
Max Revenue beat(2)-17.37%
Revenue beat(4)0
Avg Revenue beat(4)-13.81%
Min Revenue beat(4)-26.83%
Max Revenue beat(4)-4.34%
Revenue beat(8)0
Avg Revenue beat(8)-14.17%
Revenue beat(12)0
Avg Revenue beat(12)-11.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.24%
PT rev (1m)2.51%
PT rev (3m)5.57%
EPS NQ rev (1m)-59.52%
EPS NQ rev (3m)-10.53%
EPS NY rev (1m)-263.58%
EPS NY rev (3m)-357.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.36
P/S 1.1
P/FCF N/A
P/OCF 2.04
P/B 0.77
P/tB 0.77
EV/EBITDA 3.57
EPS(TTM)-1.11
EYN/A
EPS(NY)0.45
Fwd EY4.47%
FCF(TTM)-3.42
FCFYN/A
OCF(TTM)4.91
OCFY48.94%
SpS9.08
BVpS13
TBVpS13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.93%
ROE -8.65%
ROCE 4.44%
ROIC 3.51%
ROICexc 3.54%
ROICexgc 3.54%
OM 12.83%
PM (TTM) N/A
GM 67.54%
FCFM N/A
ROA(3y)4.74%
ROA(5y)-0.65%
ROE(3y)9.7%
ROE(5y)-15.85%
ROIC(3y)10.72%
ROIC(5y)N/A
ROICexc(3y)10.81%
ROICexc(5y)N/A
ROICexgc(3y)10.81%
ROICexgc(5y)N/A
ROCE(3y)13.57%
ROCE(5y)N/A
ROICexgc growth 3Y-31.83%
ROICexgc growth 5Y4.7%
ROICexc growth 3Y-31.83%
ROICexc growth 5Y4.7%
OM growth 3Y-29.16%
OM growth 5Y2.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.52%
GM growth 5Y0.95%
F-Score5
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA 1.4
Cap/Depr 248.72%
Cap/Sales 91.78%
Interest Coverage 1.99
Cash Conversion 108.73%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.71
Altman-Z 0.46
F-Score5
WACC7.53%
ROIC/WACC0.47
Cap/Depr(3y)126.62%
Cap/Depr(5y)107.23%
Cap/Sales(3y)33.7%
Cap/Sales(5y)32.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.94%
EPS Next Y-275.38%
EPS Next 2Y100.78%
EPS Next 3Y70.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-2.42%
Revenue growth 5Y1.65%
Sales Q2Q%-5.34%
Revenue Next Year-3.04%
Revenue Next 2Y-2.44%
Revenue Next 3Y-1.84%
Revenue Next 5Y-0.29%
EBIT growth 1Y21.86%
EBIT growth 3Y-30.87%
EBIT growth 5Y4.51%
EBIT Next Year44.86%
EBIT Next 3Y15.3%
EBIT Next 5Y15.47%
FCF growth 1Y-271.43%
FCF growth 3Y0.4%
FCF growth 5Y4.86%
OCF growth 1Y-13.01%
OCF growth 3Y5.06%
OCF growth 5Y3.28%

VERMILION ENERGY INC / VET FAQ

What is the fundamental rating for VET stock?

ChartMill assigns a fundamental rating of 2 / 10 to VET.


Can you provide the valuation status for VERMILION ENERGY INC?

ChartMill assigns a valuation rating of 2 / 10 to VERMILION ENERGY INC (VET). This can be considered as Overvalued.


How profitable is VERMILION ENERGY INC (VET) stock?

VERMILION ENERGY INC (VET) has a profitability rating of 3 / 10.


What is the earnings growth outlook for VERMILION ENERGY INC?

The Earnings per Share (EPS) of VERMILION ENERGY INC (VET) is expected to decline by -275.38% in the next year.